Consistent with the dysregulation in adipokine levels, metabolic syndrome has been associated an aggravation in inflammation [38,39], and this state that is characterized by increased pro-inflammatory cytokines and acute phase reactants such as CRP, IL-6, and tumor necrosis factor alpha (TNF-α) [13,14]. The gene discussed is IL6; the disease is metabolic syndrome.